Microbio is pleased to announce it has signed a distributor agreement with Bio-Gene Technology Limited, a trusted provider of innovative scientific and medical solutions in Hong Kong.
Under this agreement, Bio-Gene will become the exclusive distributor for Microbio’s InfectID™-BSI diagnostic platform in the territories of Hong Kong and Macau. This partnership marks a significant milestone for Microbio as it expands its international footprint and continues to bring cutting-edge diagnostic technology to global markets.
“We’re very excited to partner with Bio-Gene, a company with a strong reputation for excellence in the life sciences and clinical diagnostics sector,” said Johan Vanderhoeven, Chief Commercial Officer at Microbio. “Being around for more than 30 years, their deep regional expertise and strong relationships with healthcare providers make them the ideal partner to introduce our InfectID™-BSI technology to Hong Kong and Macau.”
InfectID™-BSI is a rapid molecular diagnostic test that identifies 26 pathogens responsible for >94% of bloodstream infections resulting in sepsis. Leveraging DNA melt curve analysis, InfectID™-BSI detects pathogens directly from blood samples without the need for culture, delivering results in just three hours. This CE-marked assay empowers clinicians to begin targeted treatment sooner, improving outcomes and supporting antimicrobial stewardship.
Bio-Gene, based in Hong Kong, is a well-established distributor of high-quality laboratory and medical equipment. With over 30 years of experience and a robust presence in hospitals, research institutions, and diagnostic labs across the region, Bio Gene is well-positioned to support the successful rollout of Microbio’s technology.
“This collaboration unites Bio-Gene’s expertise in distributing innovative scientific solutions across Hong Kong and Macau with Microbio’s groundbreaking advancements in pathogen detection technology. By combining our strengths, we aim to deliver cutting-edge diagnostic tools to healthcare professionals and patients, enhancing the accuracy and speed of pathogen diagnosis. At Bio-Gene, we are committed to exceeding customer expectations, and this partnership with Microbio aligns perfectly with our mission to provide transformative solutions that meet the evolving needs of our clients. Together, we look forward to revolutionizing clinical diagnostics and improving patient outcomes.” said Mr. Raymond Wong, Director of Business, at Bio-Gene.